middle.news
Mach7’s leaner platform points to a tougher but more recurring FY27
9:38am on Friday 30th of October, 2026 AEDT
•
Healthcare Technology
Read Story
Mach7’s leaner platform points to a tougher but more recurring FY27
9:38am on Friday 30th of October, 2026 AEDT
Key Points
Revenue fell 17% to A$27.9 million and net loss widened to A$8.9 million
Operating expenditure dropped 16% to A$26.7 million after A$1.9 million of restructuring costs
Recurring revenue represented 84% of total revenue and covered 87% of operating expenditure
Sales orders reached A$23.5 million, including A$4.9 million from new customers
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Mach7 Technologies (ASX:M7T)
OPEN ARTICLE